Real-World study tests Trimbow's impact on severe COPD symptoms
Disease control
Recruiting now
This study is tracking about 400 adults with severe or very severe COPD in Brazil who are taking the triple-combination inhaler Trimbow. Researchers will measure changes in symptoms and lung function over 6 months during routine doctor visits. The goal is to see how well the medi…
Sponsor: Chiesi Farmaceutica Ltda. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC